Literature DB >> 8725703

Use of depot medroxyprogesterone acetate contraception in adolescents.

A J Davis1.   

Abstract

More than 1 million teen pregnancies occur each year in the United States. DMPA offers several distinct advantages over other contraceptive methods in adolescents. The duration of effectiveness and convenience of DMPA are appealing to teens. Most teens who are current users view amenorrhea as a positive feature of DMPA. Although most young women are able to tolerate the irregular bleeding, some find the cycle disruption concerning. Satisfaction rates among adolescent DMPA users is high.

Entities:  

Keywords:  Adolescents; Adolescents, Female; Age Factors; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Contraceptive Usage; Demographic Factors; Depo-provera; Developed Countries; Family Planning; Injectables; Literature Review; Medroxyprogesterone Acetate; North America; Northern America; Population; Population Characteristics; United States; Youth

Mesh:

Substances:

Year:  1996        PMID: 8725703

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

1.  Evidence-based case review. Contraception for adolescents.

Authors:  C Davtyan
Journal:  West J Med       Date:  2000-03

2.  Why Didn't You Text Me? Poststudy Trends From the DepoText Trial.

Authors:  Cara R Muñoz Buchanan; Kathy Tomaszewski; Shang-En Chung; Krishna K Upadhya; Alexandra Ramsey; Maria E Trent
Journal:  Clin Pediatr (Phila)       Date:  2017-02-13       Impact factor: 1.168

3.  Association between depot medroxyprogesterone acetate (DMPA), physical activity and bone health.

Authors:  Opeyemi O Babatunde; Jacky J Forsyth
Journal:  J Bone Miner Metab       Date:  2013-08-07       Impact factor: 2.626

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.